Skip to main content

Advertisement

You are viewing the new article page. Let us know what you think. Return to old version

Correction to: Efficacy of intravenous plus intrathecal/intracerebral ventricle injection of polymyxin B for post-neurosurgical intracranial infections due to MDR/XDR Acinectobacter baumannii: a retrospective cohort study

The original article was published in Antimicrobial Resistance & Infection Control 2018 7:8

Correction to: Antimicrob Resist Infect Control

https://doi.org/10.1186/s13756-018-0305-5

The original article [1] contains an error in the Safety analysis sub-section of the results regarding the reported mean creatinine level. The correct mean creatinine level was 42.09 ± 18.54 μmol/L at 48 hours after polymyxin B injection instead of the reported 41.09 ± 11.46 μmol/L.

Reference

  1. 1.

    Pan S, et al. Efficacy of intravenous plus intrathecal/intracerebral ventricle injection of polymyxin B for post-neurosurgical intracranial infections due to MDR/XDR Acinectobacter baumannii: a retrospective cohort study. Antimicrob Resist Infect Control. 2018;7:8. https://doi.org/10.1186/s13756-018-0305-5.

Download references

Author information

Correspondence to Gensheng Zhang.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark